# MaxCyte, Inc. (MXCT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/MXCT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 33.82M | $ -45.70M | $ -37.04M | $ 17.94M | $ 171.49M |
| 2024 | $ 40.60M | $ -43.15M | $ -30.76M | $ 18.03M | $ 206.25M |
| 2023 | $ 44.64M | $ -41.01M | $ -27.45M | $ 18.74M | $ 232.17M |
| 2022 | $ 49.44M | $ -26.33M | $ -37.16M | $ 16.10M | $ 253.97M |
| 2021 | $ 40.29M | $ -22.68M | $ -17.25M | $ 5.68M | $ 262.90M |
| 2020 | $ 33.34M | $ -15.05M | $ -13.83M | $ 6.97M | $ 33.23M |
| 2019 | $ 27.91M | $ -16.64M | $ -13.00M | $ 7.21M | $ 13.60M |
| 2018 | $ 22.01M | $ -11.71M | $ -14.79M | $ 5.06M | $ 12.28M |
| 2017 | $ 18.84M | $ -13.36M | $ -13.86M | $ 5.03M | $ 19.60M |
| 2016 | $ 16.88M | $ -5.30M | $ -3.51M | $ 5.01M | $ 5.08M |
| 2015 | $ 13.04M | $ -4.94M | $ -386.1K | $ 5.04M | $ -3.08M |
| 2014 | $ 10.12M | $ -5.30M | $ -2.93M | $ 4.91M | $ -1.65M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.10 |
| Liabilities / Eq | 0.18 |
| Current Ratio | 8.30 |

## Other views

- [Metrics](https://sponda.capital/en/MXCT.md)
- [Charts](https://sponda.capital/en/MXCT/charts.md)
- [Compare](https://sponda.capital/en/MXCT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.